ad image
Engineered Bacteria as Precision Therapeutics for Cancer and Beyond
Oncology
Jun 23, 2025

Engineered Bacteria as Precision Therapeutics for Cancer and Beyond

Engineered bacteria are redefining the boundaries of medicine by acting as programmable, tumor-seeking therapies with broad potential across cancer and beyond.

Rethinking Inhalation Drug Development
Inhalation
Jun 23, 2025

Rethinking Inhalation Drug Development

Justin Lacombe, Ph.D., and Komal Patel explore how dry powder inhalers are expanding beyond traditional respiratory treatments to enable systemic drug delivery, highlighting key formulation, device, regulatory, and manufacturing considerations while emphasizing the value of partnering with specialized CDMOs like Experic.

Five Biotechs Approaching Critical Milestones in 2025
Biotechs
Jun 09, 2025

Five Biotechs Approaching Critical Milestones in 2025

From BLA filings to phase II data readouts and IND submissions, these five companies are at critical inflection points that could shift their valuation, clinical trajectory, or strategic partnerships before the year is out.

The Other Data Gap: Reimagining Clinical Research to Include Pregnant and Lactating Women
Pregnancy Research
May 23, 2025

The Other Data Gap: Reimagining Clinical Research to Include Pregnant and Lactating Women

David Alvaro, Ph.D., explores the historical roots, clinical consequences, and ethical failures of excluding pregnant and lactating women from clinical trials, and proposes actionable solutions to support their responsible inclusion in future research.

All That Glitters Is Not Gold Standard Science
Oversight
Jun 04, 2025

All That Glitters Is Not Gold Standard Science

The May 2025 executive order claiming to restore “Gold Standard Science” instead politicizes scientific oversight — threatening the independence and integrity of research by placing it under the control of ideologically driven appointees.

Five Exosome Biotechs to Watch: July 2025
Exosomes
Jul 01, 2025

Five Exosome Biotechs to Watch: July 2025

We profile five companies — Evox Therapeutics, Aruna Bio, Capricor Therapeutics, Kimera Labs, and Aegle Therapeutics — leading the charge to turn exosomes into tomorrow’s next-generation biologics and delivery systems, offering fresh hope for delivering complex RNA, gene editing, or protein therapies where older delivery vehicles fall short.

Strategic Biomanufacturing Partner for Multispecific Antibodies
Multispecific Abs
Apr 14, 2025

Strategic Biomanufacturing Partner for Multispecific Antibodies

Samsung Biologics' Youngsun Kim, Jina Kim, and Busol Park discuss how Samsung Biologics leverages seven strategic pillars to overcome the scientific, technical, and regulatory challenges of multispecific antibody development and manufacturing.

Building Guardrails, Not Just Pills: Rethinking Pain Management without Abuse
Abuse Deterrence
Jun 24, 2025

Building Guardrails, Not Just Pills: Rethinking Pain Management without Abuse

Protega Pharmaceuticals is redefining pain management by combining abuse-deterrent drug technology, FDA-approved RoxyBond®, and digital monitoring tools to help patients manage pain safely and prevent opioid misuse at its source.

Engineering from Within via In Situ Programming and Regeneration
In Situ Engineering
Jun 17, 2025

Engineering from Within via In Situ Programming and Regeneration

A new wave of innovation is emerging that programs and regenerates tissues in situ, or directly within the body

Unlocking Oral RNA Therapeutics: Overcoming Barriers to Gut-Stable Gene Delivery
Oral RNA
Jul 18, 2025

Unlocking Oral RNA Therapeutics: Overcoming Barriers to Gut-Stable Gene Delivery

Once considered infeasible, oral RNA delivery is now approaching clinical reality thanks to a convergence of advanced nanoparticle formulations, targeted GI strategies, and novel ingestible devices.

Recommended

Spotlight

ad image
ad image
ad image
ad image
ad image

THAT'S NICE TURNS 30: THREE DECADES OF BIOPHARMA AND THE ROAD TO THE FUTURE

featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
ad image
ad image
ad image

Nice Insights

ad image
ad image

IMPACT

#1

NIH Grants

Why NIH Grant Review ‘Efficiency’ May Endanger Public Health Research
#2
#3
#4
#5
ad image

Roundtable

View all roundtable

Editor's Picks

Videos

View all videos
Accelerating Time to Market with Rapid Testing Solutions
Testing
Apr 25, 2025
Accelerating Time to Market with Rapid Testing Solutions
Foxx Life Sciences' Single-Use Bioprocess & Lab Solutions
Single-Use Tech
May 21, 2025
Foxx Life Sciences' Single-Use Bioprocess & Lab Solutions
How Simtra Helps Clients Overcome Challenges in Biologics Manufacturing
Injectables
May 07, 2025
How Simtra Helps Clients Overcome Challenges in Biologics Manufacturing
Examining Evolving Clean Room Requirements with Michael O'Rourke
Clean Rooms
May 02, 2025
Examining Evolving Clean Room Requirements with Michael O'Rourke
At CS Analytical, Packaging is Everything
Packaging
May 30, 2025
At CS Analytical, Packaging is Everything
SaniSure's Legacy of Innovation
Single-Use Tech
May 06, 2025
SaniSure's Legacy of Innovation
Pharma's Almanac & That's Nice at INTERPHEX 2025
Events
May 05, 2025
Pharma's Almanac & That's Nice at INTERPHEX 2025
A Firsthand Look at Lisure's M++ Tech Transfer Platform
Tech Transfer
May 19, 2025
A Firsthand Look at Lisure's M++ Tech Transfer Platform
Continuous Biomanufacturing with PAK BioSolutions
Bioprocessing
May 30, 2025
Continuous Biomanufacturing with PAK BioSolutions
Wexler's Push for Sustainability in Packaging
Packaging
May 15, 2025
Wexler's Push for Sustainability in Packaging
Steri-Tek's Next-Gen Sterilization Techniques
Sterilization
May 12, 2025
Steri-Tek's Next-Gen Sterilization Techniques
Stevanato Group's Evolution
Packaging
May 20, 2025
Stevanato Group's Evolution

Latest

View all latest
Oral RNA
Jul 18, 2025
Unlocking Oral RNA Therapeutics: Overcoming Barriers to Gut-Stable Gene Delivery
Clinical Platforms
Jul 18, 2025
Why Clinical Trial Platforms Must Evolve from Tools to Strategy
Analytical
Jul 16, 2025
Compressing Analytical Timelines Without Cutting Corners
NIH Grants
Jul 16, 2025
Why NIH Grant Review ‘Efficiency’ May Endanger Public Health Research
Clinical Supply
Jul 16, 2025
Building Clinical Supply Agility in a Changing Trial Landscape
Formulation
Jul 16, 2025
Formulation and Analytics Platforms Transforming Drug Product Development
Platforms
Jul 15, 2025
Built for Speed and Scale: How CDMO Cell Line Platforms Are Reshaping Biologic Development
Australia
Jul 14, 2025
Australia as a Strategic Gateway: The Economic and Regulatory Advantages of Clinical Manufacturing Down Under
Nice Insight's State of the Industry Report 2025

Nice Insight's State of the Industry Report 2025

LEARN MORE
Mammalian Cell Culture, Biologics: Market Insight, CDMO Pricing and Competitor Benchmarking

Mammalian Cell Culture, Biologics: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Microbial Fermentation, Biologics: Market Insight, CDMO Pricing and Benchmarking

Microbial Fermentation, Biologics: Market Insight, CDMO Pricing and Benchmarking

LEARN MORE
Antibody–Drug Conjugate, ADC: Market Insight, CDMO Pricing and Competitor Benchmarking

Antibody–Drug Conjugate, ADC: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Sterile Fill Finish: Market Insight, CDMO Pricing and Competitor Benchmarking

Sterile Fill Finish: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Gene Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

Gene Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Cell Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

Cell Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Messenger Ribonucleic Acid, mRNA: Market Insight, CDMO Pricing and Competitor Benchmarking

Messenger Ribonucleic Acid, mRNA: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Plasmids Market Insight, CDMO Pricing and Competitor Benchmarking

Plasmids Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Active Pharmaceutical Ingredients, API: Market Insight, CDMO Pricing and Competitor Benchmarking

Active Pharmaceutical Ingredients, API: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Oral Solid Dose, OSD: Market Insight, CDMO Pricing and Benchmarking

Oral Solid Dose, OSD: Market Insight, CDMO Pricing and Benchmarking

LEARN MORE

Subscribe for the Newsletter

Pharma’s Almanac’s weekly newsletter, featuring industry news and must-read original content on a range of topics.

The Road To Series

030db6fe-32bf-4364-88b0-28655c88acf9
ea932e33-29ac-48c3-9e59-fea0994b10cc
cfe49a93-d81b-451e-9e07-8ba4ebfc53b8
8887a25b-41b6-430d-8d52-9722c7334914
2c58207c-1481-4629-bd23-de0d0815f2b1
e6bf6f4c-ce04-4ec3-9aa9-6c34b1c2494f